Related Experiment Video

Updated: Jun 13, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Regression of small resistance artery structural alterations in hypertension by appropriate antihypertensive

Enrico Agabiti-Rosei1, Damiano Rizzoni

  • 1Clinica Medica, Department of Medical and Surgical Sciences, University of Brescia, c/o 2a Medicina Spedali Civili di Brescia, Piazza Spedali Civili 1, Brescia, Italy.

Current Hypertension Reports
|April 29, 2010
PubMed

Insights

Effective hypertension treatment can reverse vascular structural changes. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and calcium antagonists normalized artery structure, unlike beta-blockers or diuretics.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Pharmacology

Background:

  • Hypertension leads to detrimental structural changes in systemic vasculature.
  • Vascular structure indices, like tunica media to lumen ratio, are significant prognostic indicators in hypertensive patients.
  • Reversing these vascular alterations is a key therapeutic goal in managing hypertension.

Purpose of the Study:

  • To evaluate the impact of different antihypertensive medications on the structural regression of small resistance arteries in hypertensive patients.
  • To compare the efficacy of various drug classes in normalizing vascular architecture.

Main Methods:

  • Analysis of structural changes in small resistance arteries from hypertensive patients undergoing antihypertensive therapy.
  • Assessment of the tunica media to internal lumen ratio as a key structural index.
  • Comparison of treatment effects across different classes of antihypertensive drugs.

Main Results:

  • Long-term, effective therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and calcium antagonists led to complete normalization of small resistance artery structure.
  • Beta-blockers and diuretics showed little to no improvement in vascular structural alterations.
  • Significant differences exist in the ability of antihypertensive drugs to reverse microvascular structural damage.

Conclusions:

  • Antihypertensive medications vary in their capacity to restore vascular structure.
  • Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and calcium antagonists are effective in normalizing hypertensive vascular changes.
  • Drug selection for hypertension management should consider potential benefits on vascular structure beyond blood pressure reduction.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...